Regular coffee consumption (2-3 cups/day) protects against liver cirrhosis, reduces fibrosis, prevents liver cancer, and ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosisalfapump® is ...

While the treatment options for this aggressive type of cancer ... which are linked to liver cirrhosis and other serious health ... Mechanism of Action of the Hepatitis B and D Virus Cell Entry ...

Chronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

The global cirrhosis management market is projected to grow from US$ 725 million in 2023 to US$ 1,052.3 million by 2033, with ...

A research team found out how AHCC, a standardized extract of cultured Lentinula edodes mycelia, might be able to suppress the progression of liver fibrosis.

Liver cirrhosis is a serious condition that happens when the liver becomes scarred and loses its ability to function properly ...

Galectin Therapeutics’ stock has halved since the company revealed its investigational drug failed to significantly reduce ...

LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...

There are limited effective treatment options, resulting in poor clinical ... treatment of recurrent or refractory ascites due to liver cirrhosis in December 2024, following the grant of FDA ...